Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umang Swami

Showing results (31-40 of 170) with videos related to

Pageof 17
Sort By:
Pharmacogenomics|December 19, 2019
Germline variants and response to systemic therapy in advanced prostate cancerEric Johnson, Roberto Nussenzveig, Neeraj Agarwal, et al.
Annals of Surgical Oncology|June 30, 2021
Landmark Series on Disparities in Surgical Oncology: MelanomaElliot A Asare, Umang Swami, John H Stewart
Cancer Treatment and Research Communications|February 7, 2021
Utilization of systemic therapy for treatment of advanced urothelial carcinoma: Lessons from real world experienceUmang Swami, Petros Grivas, Sumanta K Pal, et al.
Translational Cancer Research|February 4, 2022
The tango of immunotherapy and targeted therapy in metastatic renal cell carcinomaNityam Rathi, Benjamin L Maughan, Neeraj Agarwal, et al.
Cancers|June 2, 2021
Immune Checkpoint Inhibitors in Prostate CancerShobi Venkatachalam, Taylor R McFarland, Neeraj Agarwal, et al.
Trends in Cancer|June 15, 2020
Advanced Prostate Cancer: Treatment Advances and Future DirectionsUmang Swami, Taylor R McFarland, Roberto Nussenzveig, et al.
Critical Reviews in Oncology/Hematology|April 16, 2011
Eribulin -- a review of preclinical and clinical studiesUmang Swami, Imran Chaudhary, Mohammad H Ghalib, et al.
American Journal of Translational Research|August 11, 2021
Development of PARP inhibitor combinations for castration resistant prostate cancer unselected for homologous recombination repair mutationsTaylor Ryan McFarland, Adam Kessel, Umang Swami, et al.
Expert Review of Anticancer Therapy|March 7, 2022
Current and emerging role of sacituzumab govitecan in the management of urothelial carcinomaVinay Mathew Thomas, Nishita Tripathi, Neeraj Agarwal, et al.
The Oncologist|April 4, 2023
The Management of Metastatic Castrate-Sensitive Prostate Cancer: From Guidelines to Real-World PracticeGeorges Gebrael, Vinay Mathew Thomas, Umang Swami, et al.
Pageof 17

Showing results (31-40 of 170) with videos related to

Sort By:
Pageof 17
Pharmacogenomics|December 19, 2019
Germline variants and response to systemic therapy in advanced prostate cancerEric Johnson, Roberto Nussenzveig, Neeraj Agarwal, et al.
Annals of Surgical Oncology|June 30, 2021
Landmark Series on Disparities in Surgical Oncology: MelanomaElliot A Asare, Umang Swami, John H Stewart
Cancer Treatment and Research Communications|February 7, 2021
Utilization of systemic therapy for treatment of advanced urothelial carcinoma: Lessons from real world experienceUmang Swami, Petros Grivas, Sumanta K Pal, et al.
Translational Cancer Research|February 4, 2022
The tango of immunotherapy and targeted therapy in metastatic renal cell carcinomaNityam Rathi, Benjamin L Maughan, Neeraj Agarwal, et al.
Cancers|June 2, 2021
Immune Checkpoint Inhibitors in Prostate CancerShobi Venkatachalam, Taylor R McFarland, Neeraj Agarwal, et al.
Trends in Cancer|June 15, 2020
Advanced Prostate Cancer: Treatment Advances and Future DirectionsUmang Swami, Taylor R McFarland, Roberto Nussenzveig, et al.
Critical Reviews in Oncology/Hematology|April 16, 2011
Eribulin -- a review of preclinical and clinical studiesUmang Swami, Imran Chaudhary, Mohammad H Ghalib, et al.
American Journal of Translational Research|August 11, 2021
Development of PARP inhibitor combinations for castration resistant prostate cancer unselected for homologous recombination repair mutationsTaylor Ryan McFarland, Adam Kessel, Umang Swami, et al.
Expert Review of Anticancer Therapy|March 7, 2022
Current and emerging role of sacituzumab govitecan in the management of urothelial carcinomaVinay Mathew Thomas, Nishita Tripathi, Neeraj Agarwal, et al.
The Oncologist|April 4, 2023
The Management of Metastatic Castrate-Sensitive Prostate Cancer: From Guidelines to Real-World PracticeGeorges Gebrael, Vinay Mathew Thomas, Umang Swami, et al.
Pageof 17